185 related articles for article (PubMed ID: 3052780)
1. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease.
Benharroch D; Yermiahu T; Geffen DB; Prinsloo I; Gopas J; Segal S; Aboud M
Eur J Haematol; 1995 Sep; 55(3):178-83. PubMed ID: 7672090
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
4. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
[TBL] [Abstract][Full Text] [Related]
5. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
[TBL] [Abstract][Full Text] [Related]
6. The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry.
Jack AS; Kerr IB; Evan G; Lee FD
Br J Cancer; 1986 Jun; 53(6):713-9. PubMed ID: 3521694
[TBL] [Abstract][Full Text] [Related]
7. Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.
Hamatani K; Yoshida K; Kondo H; Toki H; Okabe K; Motoi M; Ikeda S; Mori S; Shimaoka K; Akiyama M
Blood; 1989 Jul; 74(1):423-9. PubMed ID: 2526666
[TBL] [Abstract][Full Text] [Related]
8. The expression of myc and ras oncogene protein in childhood lymphomas.
Sakalidou A; Kanavaros P; Tzardi M; Kalmanti M
Anticancer Res; 1996; 16(1):487-91. PubMed ID: 8615659
[TBL] [Abstract][Full Text] [Related]
9. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
11. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
[No Abstract] [Full Text] [Related]
12. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
13. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
[TBL] [Abstract][Full Text] [Related]
15. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
16. Detection of MYC gene amplification in malignant lymphomas.
Park CK; Lee CG; Lee JD
J Korean Med Sci; 1998 Apr; 13(2):159-64. PubMed ID: 9610616
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.
Kittas C; Korkolopoulou P; Pangalis GA; Tsenga A; Boussiotis VA; Spandidos DA
Leuk Lymphoma; 1990; 1(3-4):241-7. PubMed ID: 27463992
[TBL] [Abstract][Full Text] [Related]
19. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
20. Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements.
Williams ME; Frierson HF; Tabbarah S; Ennis PS
Am J Clin Pathol; 1990 Jun; 93(6):754-9. PubMed ID: 2189291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
